Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection

Completed

Conditions studied: Breast Cancer

In brief

This protocol will evaluate a new non-invasive infrared imaging system as an adjunctive tool for breast cancer detection that has been approved by the FDA. The technology and device have been developed by Infrared Sciences Corp. and has undergone more than 3 years of testing prior. The subject device's utility will be investigated with regard to its sensitivity toward breast cancer, however it records temperature data and other physiological parameters of the breast, and compares them to a database of patients with known breast health.

Key facts

Study ID

NCT00195026

Run by

Weill Medical College of Cornell University

People needed

200

Starts

2005-03-01

Last updated by the study team

2008-03-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Mammographic Breast Abnormality requiring a follow up biopsy
• Sonographic Breast Abnormality requiring a follow up biopsy
• Clinical Breast Abnormality requiring a follow up biopsy

You may not qualify if…

• Active Breast Inflammation
• Previous history of breast augmentation
• Bra size greater than DD

Where it is running

• Weill Cornell Breast Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.